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to have high sequence homologies to autochthonous human
strains, suggesting that swine can represent a reservoir of
the infection and that zoonotic transmission of HEV may play
a relevant role in industrialized countries.
Methods: Viral RNA was extracted from 10% pig faecal
suspension by using TRIZOL reagent. Two molecular meth-
ods for virus detection were compared, conventional RT-PCR
and touch-down RT-PCR. For HEV ORF 1 detection, degener-
ate primers HEVConsORF1-s1/HEVConsORF1-a1, amplifying
418 bp region and for HEV ORF 2 detection, degenerate
primers HEVORF2con-s1/HEVORF2con-a1, amplifying 197 bp
region were used.
Results: A total of 61 swine faecal samples for the ORF
1 detection and 41 swine faecal samples for the ORF 2
were analysed. For the detection of ORF 1 touch-down RT-
PCR gave us higher percentage of positive results (31%) in
comparison to the conventional RT-PCR (26%). When the
touch-down RT-PCR was used for the ORF 2 ampliﬁcation
only 22% of samples were determined positive in comparison
to the conventional RT-PCR detecting 27% positive samples.
These results indicate that an accurate optimization of the
RT-PCR method is necessary for HEV detection in faecal sam-
ples.
Conclusion: This work represents the ﬁrst description of
HEV in Slovenian pig herds and conﬁrms the presence of the
virus in pigs with diarrhoea and also in apparently healthy
pigs. These ﬁnding is important because of the potential risk
of porcine HEV transmission to humans, either by contact
with infected pig or by ingestion of contaminated under-
cooked meat and meat products.
doi:10.1016/j.ijid.2008.05.345
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Investigating Infectious Disease Emergence from Wildlife
- A Transdisciplinary Approach
H.E. Field
Biosecurity Queensland, Brisbane, Australia
Background: Nearly 75% of all emerging infectious dis-
eases (EIDs) that impact or threaten human health are
zoonotic. The majority have spilled from wildlife reservoirs,
either directly to humans or via domestic animals. The emer-
gence of many can be attributed to predisposing factors such
as global travel, trade, agricultural expansion, deforesta-
tion/habitat fragmentation, and urbanization; such factors
increase the interface and/or the rate of contact between
human, domestic animal, and wildlife populations, thereby
creating increased opportunities for spillover events to
occur.
Methods: Infectious disease emergence can be regarded
as primarily an ecological process. The epidemiologic
investigation of EIDs associated with wildlife requires a
comprehensive transdisciplinary approach that includes an
understanding of the ecology of the wildlife species, and
an understanding of human behaviors that increase risk of
exposure. Investigations of the emergence of Nipah virus in
Malaysia in 1999 and SARS in China in 2003 provide useful
case studies.
Results: The emergence of Nipah virus was (in part) asso-
ciated with the encroachment of commercial pig farms into
forested areas. The movement of pigs for sale and slaugh-
ter in turn led to the rapid spread of infection to southern
peninsular Malaysia, where the high-density, largely urban
pig populations facilitated transmission to humans. Iden-
tifying the factors associated with the emergence of SARS
in southern China requires an understanding of the ecology
of infection both in the natural reservoir and in secondary
market reservoir species. A necessary extension of under-
standing the ecology of the reservoir is an understanding of
the trade, and of the social and cultural context of wildlife
consumption.
Conclusions: Emerging infectious diseases originating
from wildlife populations will continue to threaten public
health. Mitigating and managing the risk requires an appre-
ciation of the connectedness between human, livestock and
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Background: The rapid and reliable detection of emerg-
ing zoonoses is critical to effective management of these
diseases. We have developed four multiplexed RT-PCR assay
panels that can rapidly detect high priority agricultural
pathogens, including Foot and Mouth Disease Virus and Avian
Inﬂuenza in environmental and clinical samples. The use of
bead-based liquid arrays has proven to be a well adapted and
versatile technology that can be custom tailored to rapidly
screen for both DNA and RNA in a single tube. Previously we
had, in collaboration with the CDC, developed another panel
for human biological threats. Our assays have been tested by
researchers in multiple public health and USDA laboratories
and proven robust.
Methods: Multiplexed PCR assays are developed at LLNL
through a proven process that includes sequencing and bioin-
formatics leading to TaqMan and multiplexed PCR assays. We
have utilized the Luminex X-Map system for development of
all panels. The process involves an end-point RT-PCR fol-
lowed by hybridization to a mixture of probe-conjugated
polystyrene beads that can be readily classiﬁed by ﬂow-
cytometry. Up to a maximum of 100 unique bead classes, and
thus RT-PCR products can be identiﬁed using this system.
Results: With the USDA and multiple university partners,
multiplexed RT-PCR assays both sensitive and speciﬁc for
multiple biothreat agents have been developed. We have
demonstrated that these assays are as selective as TaqMan
assays with sensitivities ranging from 10-10000 genomes.
These assays have been tested for proﬁciency in the ﬁeld
and proven of value.
Conclusions:Multiplexed assays providemany advantages
over other methods. In the event of a public health emer-
gency, these assays can provide rapid, sensitive, speciﬁc
and cost effective means of screening many samples. Addi-
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tionally, the rapid detection of agricultural pathogens is of
great importance as most emerging infectious diseases are
zoonoses.
doi:10.1016/j.ijid.2008.05.347
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Epidemiologic Evaluation of the Immunity Against Hepati-
tis B in Alexandria, Egypt
A. Reda, M. Arafa ∗
High Institute of Public Health, Alexandria, Egypt
Background: Hepatitis B (HB) vaccine represents one of
the major achievements in the 20th century. The most
important epidemiologic factor affecting the chronic car-
rier rate is age of infection. The earlier in life an infection
occurs, the higher the probability that this infection will
result in chronic carriage.
Methods: A seroepidemiologic study was conducted to
examine the impact of HB vaccination on the carrier state
among a vaccinated group of children (1000) compared to
a non-vaccinated group (500) aged 6 years in Alexandria,
Egypt.
Results: The rate of HbsAg positivity among the vacci-
nated group was found to be 0.8% compared to 2.2% among
the non-vaccinated group. The study showed that the efﬁ-
cacy of HB vaccine in preventing the carriage of HbsAg, 5
years after full course vaccination, was estimated to be
around 67%. However, long-term monitoring should continue
to conﬁrm the efﬁcacy of the vaccine in preventing chronic
carrier state. On the other hand, studying the exposure to
some risk factors associated with hepatitis B virus (HBV)
infection revealed more or less a similar pattern of exposure
among both vaccinated and unvaccinated children.
Conclusion: It can be concluded that the signiﬁcantly
lower rate of HbsAg positivity among the vaccinated com-
pared to the rate among the non-vaccinated is attributed to
the preventive effect of the vaccine.
doi:10.1016/j.ijid.2008.05.348
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Long-term Efﬁcacy and Immune Memory of Neonatal
Recombinant Hepatitis B Vaccination in Adolescents Aged
13—14 Years
C.Y. Lu ∗, Y.H. Ni, L.Y. Chang, C.Y. Lee, D.S. Chen, L.M.
Huang
National Taiwan University Hospital, Taipei, Taiwan
Background: The plasma-derived hepatitis B virus (HBV)
vaccine has been replaced by recombinant HBV vaccine since
1992 in Taiwan. The duration of immunity conferred by the
recombinant HBV vaccine is unknown. This study aimed to
investigate the long-term protective efﬁcacy of recombinant
HBV vaccine and booster responses in adolescents who had
received recombinant HBV vaccine at their infancy 13—14
years ago.
Methods: In 2007, 835 13- to 14-year-old Taiwanese
healthy middle school students, who had been vaccinated
with recombinant HBV vaccines in infancy in 1993—1994,
were recruited for the screening of HBV seromarkers. The
immune responses to booster HBV vaccines were evaluated
in 573 subjects who were seronegative. A second or third
booster was given following a schedule of 0—1—6 months for
those who remained seronegative after one dose of booster.
Anti-HBs titers were checked 7—10 days after the boosters.
Results: While the HBV vaccine remained highly efﬁ-
cacious in reducing HBsAg positive rate, 71.9% of the
vaccinees had no detectable protective anti-HBs. Following
one booster dose, anti-HBs remained undetectable in 25.9%
(135/522) of subjects with complete 3-doses HBV vaccina-
tion in infancy. A second booster reduced the seronegative
rate to 6.1% (7/115). After the third booster only one subject
(14.3%, 1/7) remained seronegative.
Conclusions: Up to 25.9% percent of adolescents who
were fully vaccinated with recombinant HBV vaccine in their
infancy have lost their immune memory against HBV 13—14
years later. No immediate need of HBV booster was found as
most subjects were well protected at this stage. However,
the decay of immune memory may raise concerns about the
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The purpose of the study was to assess the frequency
and type of adverse events after an inﬂuenza vaccination
in a population of health care workers, consisting of 897
adults in 7 medical centers in Iran, evaluated from October
2006 to February 2007. Fifty-seven percent of the subjects
(513 persons) were male. The mean age of the subjects
was 35.9± 8.1 years (range 19—58). In each medical center,
participants received one dose of the inﬂuenza virus sub-
unit vaccine inactivated with formaldehyde. Subjects were
evaluated 48 hours after their vaccination for symptoms
and signiﬁcant health events for possible adverse events.
Local and systemic reactions were reported by 192 (23.2%)
and 207 (26.1%) persons, respectively. The most common
adverse events to the inﬂuenza vaccine were skin red-
ness (39 cases), in duration (77 cases), pruritus (23 cases)
and pain (181 cases) as local reactions, while fever (84
cases), myalgia (142 cases), headache (94 cases) and weak-
ness (123 cases) were the most common systemic reactions.
Among all the participants, one case of Guillain-barre syn-
drome was reported. A fever of over 38.5 ◦C was found
in 1.4% of the study participants. The adverse reaction
remained more common in women than men after adjust-
ment for other factors (OR = 3.1). Occurrence of systemic
